The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Feb 2011 15:40

RNS Number : 8268B
Surgical Innovations Group PLC
24 February 2011
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

 

 

 Surgical Innovations Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Change in Total Voting Rights

X

3. Full name of person(s) subject to thenotification obligation: iii

Rensburg Sheppards Investment Management Limited

4. Full name of shareholder(s)  (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

21st February 2011

6. Date on which issuer notified:

23rd February 2011

7. Threshold(s) that is/are crossed orreached: vi, vii

 Below 3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

Ordinary Shares

GB0004016704

 

11,593,000

 

11,593,000

 

11,493,000

 

2.93%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

11,493,000

2.93%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Client holdings registered in the name of Nominee companies 100% owned by Rensburg Sheppards Investment Management Limited.

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Phil Beardwell Chartered FCSI

Senior Compliance Manager

 

15. Contact telephone number:

020 7597 1356

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Rensburg Sheppards Investment Management Limited

Contact address

(registered office for legal entities)

 

Quayside House

Canal Wharf

Leeds LS11 5PU

Phone number & email

 

0113 236 4171

mike.rigby@rsim.co.uk

Other useful information

(at least legal representative for legal persons)

 

Mike Rigby

(Head of Compliance)

B: Identity of the notifier, if applicable

Full name

 

Philip Martin Beardwell

Contact address

 

2 Gresham Street

London

EC2V 7QN

Phone number & email

 

020 7597 1356

phil.beardwell@rsim.co.uk

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

Senior Compliance Manager

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUSOVRABAUUAR
Date   Source Headline
25th Sep 202011:50 amRNSHolding(s) in Company
23rd Sep 20205:20 pmRNSHolding(s) in Company
21st Sep 20201:46 pmRNSHolding(s) in Company
18th Sep 20204:08 pmRNSResult of AGM
17th Sep 202012:54 pmRNSResult of Fundraise
17th Sep 20207:01 amRNSProposed Fundraise
8th Sep 20207:00 amRNSHalf-year Report
21st Aug 20207:00 amRNSNotice of results and Change of AGM 2020 Date
10th Aug 20205:57 pmRNSHolding(s) in Company
10th Jun 20207:00 amRNSPostponement of the Annual General Meeting 2020
4th Jun 20204:50 pmRNSDirector/PDMR Shareholding
4th Jun 20207:00 amRNSNHS Sustainability Webinar
28th May 20207:00 amRNSUpdate on trading &extension to banking facilities
31st Mar 20207:00 amRNSFinal Results
27th Mar 20203:05 pmRNSNotice of results and trading update
13th Jan 20207:00 amRNSYear-end Trading Update
11th Nov 20196:09 pmRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSDirector/PDMR Shareholding
5th Nov 20192:56 pmRNSDirector/PDMR Shareholding
25th Oct 20193:12 pmRNSDirector/PDMR Shareholding
7th Oct 20194:12 pmRNSHolding(s) in Company
27th Sep 20193:40 pmRNSExercise of Options, Issue of Equity and TVR
17th Sep 20197:00 amRNSHalf-year Report
3rd Sep 20197:00 amRNSNotice of Results
19th Jun 20194:03 pmRNSResult of AGM
19th Jun 20197:00 amRNSBoard and management structure changes
7th Jun 20197:00 amRNSTrading Update
6th Jun 20192:00 pmRNSHolding(s) in Company
29th May 20193:06 pmRNSExercise of Options, PDMR Shareholding & TVR
23rd May 201910:38 amRNSHolding(s) in Company
22nd May 201910:16 amRNSHolding(s) in Company
13th May 20196:25 pmRNSNotification of Major Interest in Shares
27th Mar 20197:00 amRNSGrant of Options
15th Mar 20194:27 pmRNSDirector/PDMR Shareholding
12th Mar 20197:00 amRNSFinal Results
28th Feb 20196:18 pmRNSExercise of Options & Total Voting Rights
28th Feb 20197:00 amRNSAppointment of CEO & changes in senior management
27th Feb 20197:00 amRNSNotice of Results
20th Feb 20197:00 amRNSUpdate on contingency planning for no-deal Brexit
14th Jan 20197:00 amRNSYear-end Trading Update
3rd Dec 20187:00 amRNSAppointment of Nominated Adviser and Broker
6th Nov 20187:00 amRNSSurgical robot technology UK distribution deal
16th Oct 201810:53 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSCE mark certification obtained for CELLIS range
11th Sep 201810:23 amRNSDirector/PDMR Shareholding
11th Sep 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSCE mark validation indicated for CELLIS range
22nd Aug 20187:00 amRNSNotice of Results
26th Jun 20184:41 pmRNSResult of AGM
26th Jun 20187:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.